Board Appointment

Advanced Medical Solutions Grp PLC 11 April 2006 For immediate release 11 April 2006 Advanced Medical Solutions Group plc ('AMS' or 'the Company') Board Appointment Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, today announces that Mr. Andrew Christopher Meredith has been appointed to the Board as an Executive Director. Mr. Meredith, age 39, joined AMS in July 2005 as Group Commercial Director with the objective of integrating sales, marketing, customer services and business development across the Company. He formerly held senior commercial roles within Europe with Banner Pharmacaps Inc. and Cardinal Health Inc. and gained medical device experience with Smiths Group plc. This realignment has been completed and the commercial resources organised in line with the Company's market and partner focus. New Business Development VPs have been appointed to support European and US customers for the Company's branded partner business and the UK sales team has been strengthened behind the Company's LiquiBandTM wound closure adhesive and ActivHeal(R) advanced woundcare range, which are sold directly into the NHS. Mr Meredith has an interest in 500,000 shares in the Company allocated to him under the Company's Long Term Incentive Plan. These were granted on 12 October 2005. There are no other matters which are required to be announced with regards to this appointment under paragraph (g) of Schedule 2 of the AIM Rules. Commenting on this announcement Dr. Geoffrey N. Vernon, Non-Executive Chairman of AMS, stated: 'Since joining AMS, Chris has made a major contribution to the continued successful commercialisation of the Company's technologies. His appointment to the Board underlines the Board's confidence in his ability to continue to drive the Company's future revenue and earnings growth.' For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508 Don Evans, Chief Executive Mary Tavener, Finance Director www.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000 Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development and manufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative and technologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move from product design and development through to production and delivery ready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology in cyanoacrylate based tissue adhesives that offer benefits over sutures and staples for closing wounds sold direct to hospitals or through distributors. AMS' technology and products currently serve the majority of the key global markets and strategic partners. This information is provided by RNS The company news service from the London Stock Exchange
UK 100